Procept BioRobotics [PRCT] vs Stryker [SYK] Detailed Stock Comparison

Procept BioRobotics Corporation

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Procept BioRobotics Corporation wins in 4 metrics, Stryker Corporation wins in 16 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Procept BioRobotics Corporation Stryker Corporation Better
P/E Ratio (TTM) -14.09 39.21 Stryker Corporation
Price-to-Book Ratio 3.86 5.62 Procept BioRobotics Corporation
Debt-to-Equity Ratio 21.45 72.97 Procept BioRobotics Corporation
PEG Ratio -0.27 0.72 Stryker Corporation
EV/EBITDA -12.39 19.90 Stryker Corporation
Profit Margin (TTM) -31.02% 12.92% Stryker Corporation
Operating Margin (TTM) -40.64% 27.24% Stryker Corporation
EBITDA Margin (TTM) N/A 27.24% N/A
Return on Equity -24.89% 15.08% Stryker Corporation
Return on Assets (TTM) -12.46% 7.92% Stryker Corporation
Free Cash Flow (TTM) $-58.34M $4.28B Stryker Corporation
Dividend Yield 0.64% 0.97% Stryker Corporation
1-Year Return -54.60% -20.27% Stryker Corporation
Price-to-Sales Ratio (TTM) 4.59 5.02 Procept BioRobotics Corporation
Enterprise Value $1.21B $138.30B Stryker Corporation
EV/Revenue Ratio 3.92 5.51 Procept BioRobotics Corporation
Gross Profit Margin (TTM) 60.63% 64.54% Stryker Corporation
Revenue per Share (TTM) $6 $66 Stryker Corporation
Earnings per Share (Diluted) $-1.72 $8.40 Stryker Corporation
Beta (Stock Volatility) 0.93 0.93 Stryker Corporation
Short % of Float 12.30% 1.20% Stryker Corporation

Procept BioRobotics Corporation vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

PRCT
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics Corporation-1.61%-0.49%6.04%0.27%-20.64%-14.40%
Stryker Corporation0.58%-3.58%1.42%-23.29%-19.39%-15.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics Corporation-54.60%-18.98%-34.18%-34.18%-34.18%-34.18%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: Procept BioRobotics Corporation vs Stryker Corporation

MetricPRCTSYK
Market Information
Market Cap i$1.37B$126.25B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i961,9421,881,406
90 Day Avg. Volume i1,216,3472,161,139
Last Close$26.33$295.00
52 Week Range$19.35 - $66.85$281.00 - $404.87
% from 52W High-60.61%-27.14%
All-Time High$103.81 (Nov 11, 2024)$406.19 (Jan 27, 2025)
% from All-Time High-74.64%-27.37%
Growth Metrics
Quarterly Revenue Growth0.12%0.11%
Quarterly Earnings Growth0.12%0.56%
Financial Health
Profit Margin (TTM) i-0.31%0.13%
Operating Margin (TTM) i-0.41%0.27%
Return on Equity (TTM) i-0.25%0.15%
Debt to Equity (MRQ) i21.4572.97
Cash & Liquidity
Book Value per Share (MRQ)$6.50$58.61
Cash per Share (MRQ)$5.08$10.71
Operating Cash Flow (TTM) i$-48,985,000$5.04B
Levered Free Cash Flow (TTM) i$-23,916,124$4.17B
Dividends
Last 12-Month Dividend Yield i0.64%0.97%
Last 12-Month Dividend i$0.38$3.40

Valuation & Enterprise Metrics Analysis: Procept BioRobotics Corporation vs Stryker Corporation

MetricPRCT (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-14.0939.21
Forward P/E i-28.3819.67
PEG Ratio i-0.270.72
Price to Sales (TTM) i4.595.02
Price to Book (MRQ) i3.865.62
Market Capitalization
Market Capitalization i$1.37B$126.25B
Enterprise Value i$1.21B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i3.925.51
Enterprise to EBITDA i-12.3919.90
Risk & Other Metrics
Beta i0.930.93
Book Value per Share (MRQ) i$6.50$58.61

Financial Statements Comparison: Procept BioRobotics Corporation vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPRCT (2025)SYK (2025)
Revenue/Sales i308.05M25.12B
Cost of Goods Sold i111.83M9.05B
COGS % of Revenue i36.3%36.0%
Gross Profit i196.23M16.07B
Gross Margin i63.7%64.0%
Research & Development i71.28M1.62B
Operating Income (EBIT) i-103.86M5.06B
Operating Margin i-33.7%20.1%
EBITDA i-85.41M6.48B
EBITDA Margin i-27.7%25.8%
Pre-Tax Income i-95.38M4.51B
Pre-Tax Income % of Revenue i-31.0%18.0%
Income Tax i190,0001.27B
Income Tax % of Revenue i0.1%5.0%
Net Income (Profit) i-95.57M3.25B
Profit Margin i-31.0%12.9%

Balance Sheet & Liquidity Metrics

MetricPRCT (2025)SYK (2025)
Cash & Equivalents i286.50M4.01B
Total Current Assets i450.38M14.76B
Total Current Assets % of Revenue i146.2%58.7%
Total Current Liabilities i65.80M7.79B
Total Current Liabilities % of Revenue i21.4%31.0%
Long-Term Debt i76.27M14.86B
Long-Term Debt % of Revenue i24.8%59.2%
Total Shareholders Equity i365.87M22.42B
Retained Earnings i-641.56M20.47B
Retained Earnings % of Revenue i-208.3%81.5%
Property, Plant & Equipment i21.51M1.79B

Cash Flow Statement Comparison

MetricPRCT (2025)SYK (2025)
Operating Cash Flow i-50.56M4.70B
Operating Cash Flow % of Revenue i-16.4%18.7%
Capital Expenditures i-9.36M-761.00M
Free Cash Flow i-58.34M4.28B
FCF Margin i-18.9%17.1%
Debt Repayment iN/A-1.40B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPRCTSYK
Shares Short i5.87M4.42M
Short Ratio i3.251.95
Short % of Float i12.30%1.20%
Shares Outstanding i56.32M382.50M
Float Shares i55.12M346.55M
% Held by Insiders i3.22%5.37%
% Held by Institutions i104.61%82.09%
% Held by Public i-7.83%12.54%

Dividend Analysis & Yield Comparison: Procept BioRobotics Corporation vs Stryker Corporation

MetricPRCTSYK
Last 12-Month Dividend i$0.38$3.40
Last 12-Month Dividend Yield i0.64%0.97%
3-Year Avg Annual Dividend i$0.53$3.23
3-Year Avg Dividend Yield i0.12%0.24%
3-Year Total Dividends i$1.59$9.69
Ex-Dividend DateMar 31, 2025Dec 31, 2025